达威股份(300535) - 2022 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2022 was ¥112,927,957.16, a decrease of 8.84% compared to ¥123,883,608.40 in the same period last year[6] - Net profit attributable to shareholders was ¥4,474,714.71, down 52.91% from ¥9,502,463.29 year-on-year[6] - Basic earnings per share decreased by 52.41% to ¥0.0435 from ¥0.0914 in the same period last year[6] - The net profit for the first quarter of 2022 was CNY 3,805,665.11, a decrease of 56.7% compared to CNY 8,805,670.02 in the same period last year[24] - The total operating revenue for the first quarter was CNY 108,092,051.74, down from CNY 115,046,529.57 year-on-year[24] - The operating profit decreased to CNY 4,837,518.46, compared to CNY 10,037,653.57 in the previous year, reflecting a decline of 51.9%[24] - The total comprehensive income for the first quarter was CNY 3,353,510.31, significantly lower than CNY 9,242,522.68 in the previous year[25] Cash Flow and Assets - The net cash flow from operating activities was -¥7,155,320.64, representing a decline of 876.88% compared to -¥732,468.12 in the previous year[6] - Cash and cash equivalents decreased by 73.96% to ¥11,938,656.60 from ¥45,838,801.49 at the beginning of the period[9] - The company's cash and cash equivalents decreased to CNY 11,938,656.60 from CNY 45,838,801.49 at the beginning of the year[19] - The cash flow from operating activities showed a net outflow of CNY 7,155,320.64, compared to a smaller outflow of CNY 732,468.12 in the same period last year[27] - The company reported a decrease in cash and cash equivalents to CNY 11,217,154.70 at the end of the quarter, down from CNY 73,181,418.23 at the end of the previous year[28] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,214,092,055.02, down 4.96% from ¥1,277,431,071.29 at the end of the previous year[6] - As of March 31, 2022, total assets amounted to CNY 1,214,092,055.02, a decrease from CNY 1,277,431,071.29 at the beginning of the year[21] - Total liabilities as of March 31, 2022, were CNY 254,542,636.95, down from CNY 322,285,961.66 at the beginning of the year[21] - The company's total equity as of March 31, 2022, was CNY 959,549,418.07, slightly up from CNY 955,145,109.63 at the beginning of the year[21] Investments and Shareholder Information - Long-term equity investments increased by 37.07% to ¥73,945,101.71, primarily due to increased external investments[9] - The number of ordinary shareholders at the end of the reporting period was 9,746[12] - The company holds a 26% stake in Shandong Zhongke New Materials Technology Co., Ltd. after investing CNY 39 million, with a total financing amount of CNY 50 million planned for this round[15] - The company established a wholly-owned subsidiary, Chengdu Dawi Plastic Products Co., Ltd., with an investment of CNY 30 million in February 2022[16] - The company plans to invest between CNY 46 million and CNY 48 million to increase its stake in Anhui Wensheng Medical Devices Co., Ltd., aiming for a 51.5% ownership after the capital increase[17] Expenses - The company reported a 52.49% reduction in financial expenses, amounting to ¥863,266.28, due to decreased interest expenses from repaying bank loans[9] - The company incurred a total of CNY 8,004,520.06 in R&D expenses, down from CNY 10,075,607.89 in the same period last year, indicating a reduction of 20.6%[24] - The total cash outflow from investing activities was CNY 33,999,739.06, compared to CNY 38,282,393.51 in the previous year, reflecting a decrease of 11.9%[28] - The financing activities generated a net cash inflow of CNY 8,904,705.95, a significant decrease from CNY 54,162,298.53 in the same period last year[28]